Ticker
ACRSCompany Name
ACLARIS THERAPEUTICS INCSector
HealthcareIndustry
Diagnostics & ResearchExchange
NASDAQDate | Total Assets | Gross Profit | Gross Profits to Assets |
---|---|---|---|
6/30/2025 | $ 189.15M | $ 1.71M | 0.91% |
3/31/2025 | $ 198.09M | $ 2.64M | 1.33% |
12/31/2024 | $ 220.33M | $ 3.26M | 1.48% |
9/30/2024 | $ 182.39M | $ 14.49M | 7.95% |
6/30/2024 | $ 161.07M | $ 13.65M | 8.47% |
3/31/2024 | $ 174.06M | $ 13.07M | 7.51% |
12/31/2023 | $ 197.41M | $ 13.17M | 6.67% |
9/30/2023 | $ 218.35M | $ 8.27M | 3.79% |
6/30/2023 | $ 235.65M | $ 17.97M | 7.63% |
3/31/2023 | $ 229.71M | $ 18.15M | 7.9% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
GP / Assets
(=) GPA
GPA for ACLARIS THERAPEUTICS INC is calculated as follows: GP [ $ 1.12M ] / Assets [ $ 71.9M ]
(=) GPA [ 1.56% ]
Minimum
Jun 30, 2021
Maximum
Jun 30, 2024
Average
Median
filtered constituents | 4.14K |
---|---|
min | -50.32% |
max | 83.98% |
average | 20.15% |
median | 15.34% |
std | 19.95% |